Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs.

Farooq, Hamzah Z; Cirillo, Daniela M; Hillemann, Doris; Wyllie, David; van der Werf, Marieke J; Ködmön, Csaba; Nikolayevskyy, Vlad

Farooq, Hamzah Z; Cirillo, Daniela M; Hillemann, Doris; Wyllie, David; van der Werf, Marieke J; Ködmön, Csaba; Nikolayevskyy, Vlad.

Emerg Infect Dis ; 27(3): 985-987, 2021 03.

Article em En | MEDLINE | ID: mdl-33622487

ABSTRACT

ABSTRACT

We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and repurposed tuberculosis drugs exists, but its availability is limited.

Assuntos

Mycobacterium tuberculosis; Preparações Farmacêuticas; Tuberculose Resistente a Múltiplos Medicamentos; Antituberculosos/uso terapêutico; Diarilquinolinas; Europa (Continente); Humanos; Testes de Sensibilidade Microbiana; Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico

Palavras-chave

Europe; Mycobacterium tuberculosis; antimicrobial resistance; bacteria; drug susceptibility; drugs; public health; respiratory infections; testing; tuberculosis; tuberculosis and other mycobacteria

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Emerg Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google